NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $480,000 | -60.8% | 89,000 | -1.9% | 0.00% | -50.0% |
Q4 2021 | $1,225,000 | -0.9% | 90,700 | +30.8% | 0.01% | -11.1% |
Q3 2021 | $1,236,000 | +22.5% | 69,321 | +16.9% | 0.01% | +12.5% |
Q2 2021 | $1,009,000 | -21.5% | 59,321 | -7.7% | 0.01% | -33.3% |
Q1 2021 | $1,286,000 | +26.5% | 64,300 | +7.5% | 0.01% | +20.0% |
Q4 2020 | $1,017,000 | +5.2% | 59,800 | +2.6% | 0.01% | -9.1% |
Q3 2020 | $967,000 | -33.3% | 58,300 | -6.8% | 0.01% | -38.9% |
Q2 2020 | $1,449,000 | +29.7% | 62,550 | 0.0% | 0.02% | +12.5% |
Q1 2020 | $1,117,000 | -7.7% | 62,550 | +11.6% | 0.02% | +23.1% |
Q4 2019 | $1,210,000 | +296.7% | 56,050 | +553.6% | 0.01% | +225.0% |
Q3 2019 | $305,000 | 0.0% | 8,575 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $305,000 | +7.0% | 8,575 | +1.2% | 0.00% | 0.0% |
Q1 2019 | $285,000 | – | 8,475 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |